EUVIMEDOpdag EUVIMED
BeobachtungsstudieVergleichsstudieOpen access

Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single‐Center Study

Krishna Prasad Kurpad, Mounica Vorla, Talha Bin-Farooq, Roma Mehta, Naveed Adoni, Uday B Kanakadandi, Issam D Moussa, Sanjay S Mehta

Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 548-553

DOI: 10.1002/ccd.70667 ↗

At a glance

Beobachtungsstudie in Catheterization and Cardiovascular Interventions, published online on 2026-05-31. Written by Krishna Prasad Kurpad and 7 co-authors. Institution: Division of Cardiology, Carle Foundation Hospital, Urbana, Illinois, USA. Major MEDLINE topics: Percutaneous Coronary Intervention, Anticoagulants, Fibrinolytic Agents, Platelet Aggregation Inhibitors. 21 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Balancing ischemic and bleeding risks in patients undergoing percutaneous coronary intervention (PCI) who require anticoagulation remains a clinical challenge. While dual antithrombotic therapy (DAT) with a P2Y12 inhibitor and an oral anticoagulant reduces long‐term bleeding risk, the optimal duration of triple antithrombotic therapy (TAT) in the immediate post‐procedural phase is uncertain.

Aims

We aimed to evaluate clinical outcomes of short‐duration ({7 days) of TAT to extended‐duration (≥ 7 days) of triple therapy following PCI.

Methods

We conducted a retrospective observational study of 172 patients who underwent PCI. Of these, 109 received TAT for < 7 days, and 63 received TAT for ≥ 7 but < 28 days. The primary outcome was a composite endpoint of cardiovascular mortality, myocardial infarction, target lesion revascularization, and definite or probable stent thrombosis at 1 year. Secondary outcomes were gastrointestinal bleeding (BARC > 3) and intracranial hemorrhage.

Results

There were no statistically significant differences between the two groups in composite outcome (cardiovascular mortality, myocardial infarction, target vessel revascularization, or stent thrombosis at 1 year). Similarly, rates of major bleeding events did not differ significantly between the groups.

Conclusion

Early de‐escalation of TAT (within 7 days) demonstrated similar clinical outcomes to longer durations (< 7 days). Larger randomized controlled trials are warranted to further validate these findings.

Subjects

MeSH terms (MEDLINE)

Percutaneous Coronary InterventionAnticoagulantsFibrinolytic AgentsPlatelet Aggregation InhibitorsCoronary Artery DiseaseCoronary ThrombosisDual Anti-Platelet TherapyPurinergic P2Y Receptor AntagonistsHumansRetrospective StudiesMaleTime FactorsFemaleTreatment OutcomeAgedRisk FactorsAdministration, OralMiddle AgedHemorrhageDrug Administration ScheduleRisk AssessmentDrug Therapy, CombinationDuration of Therapy

Author keywords

P2Y12 inhibitorsacute coronary syndromedual antithrombotic therapyobservational studyoral anticoagulantstriple drug therapy

Substances

AnticoagulantsFibrinolytic AgentsPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Authors and institutions

  • Division of Cardiology, Carle Foundation Hospital, Urbana, Illinois, USA.
  • CICOM/University of Illinois Urbana Champaign, Champaign, Illinois, USA.
  • Department of Internal Medicine, Carle Foundation Hospital, Urbana, Illinois, USA.
  • Loyola University, Illinois, Chicago, Illinois, USA.

Cite

APA

Kurpad, K. P., Vorla, M., Bin-Farooq, T., Mehta, R., Adoni, N., Kanakadandi, U. B., Moussa, I. D., & Mehta, S. S. (2026). Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single‐Center Study. Catheterization and Cardiovascular Interventions, 108(2), 548-553. https://doi.org/10.1002/ccd.70667

Vancouver

Kurpad KP, Vorla M, Bin-Farooq T, Mehta R, Adoni N, Kanakadandi UB, et al. Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single‐Center Study. Catheterization and Cardiovascular Interventions. 2026;108(2):548-553. doi:10.1002/ccd.70667

BibTeX
@article{Kurpad2026,
  author = {Kurpad, Krishna Prasad and Vorla, Mounica and Bin-Farooq, Talha and Mehta, Roma and Adoni, Naveed and Kanakadandi, Uday B and Moussa, Issam D and Mehta, Sanjay S},
  title = {Short Versus Extended Duration of Triple Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients Requiring Oral Anticoagulation: A Retrospective Single‐Center Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {108},
  number = {2},
  pages = {548--553},
  doi = {10.1002/ccd.70667}
}
Start for free →